TerminatedPhase 3

Treatment of Elderly Subjects With Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type

Stopped: The study was discontinued prematurely on 25 February 2008 due to slow enrollment

United States60 participantsStarted 2005-12

Plain-language summary

This is a 10-week study with bifeprunox and placebo in elderly subjects with psychosis and behavioral disturbances associated with dementia of the alzheimer's type.

Who can participate

Age range65 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis of dementia of the Alzheimer's type Exclusion Criteria: * History of seizure disorder * Clinically significant electrocardiogram (ECG) * Clinical or radiological evidence of stroke, vascular dementia or dementia due to substance abuse, or head trauma

What they're measuring

Brief Psychiatric Rating Scale (BPRS) Total Score

Timeframe: 10 weeks

Trial details

NCT IDNCT00160147

SponsorSolvay Pharmaceuticals

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2008-01

View on ClinicalTrials.gov More Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type trials